Major trial to test multiple drugs for progressive supranuclear palsy

A clinical trial that will test three drugs concurrently, and could include more, represents new hope for patients with progressive supranuclear palsy (PSP), an incurable neurodegenerative disorder that usually kills within seven years after symptoms start.

Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer – Biotech Investments

Biophytis / Key word(s): Miscellaneous/Miscellaneous Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer 14-Sep-2023 / 07:00 CET/CEST Biophytis Strengthens

September 15, 2023

In children, Covid is tied to higher risk of type 2 diabetes

It may be time to add Covid-19 infection to the list of possible risk factors for developing type 2 diabetes at a young age. An

October 14, 2024

MDMA Assisted Therapy Approval And Commercialization Projected Within Calendar 2024 Timeline

As the Psychedelic Science 2023 Conference in Denver wears on, interesting tidbits of data are emerging into the public sphere. As attendees of the conference—hosted

June 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.